Genenta Science S.p.A annual stock-based compensation
2019
2020
2021
2022
2023
2024
2025
Genenta Science S.p.A Stock-Based Compensation Growth & History (GNTA)
Genenta Science S.p.A's stock-based compensation was €1.0M for fiscal 2025.
View full Genenta Science S.p.A company overviewGenenta Science S.p.A annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €1.0M | €162,483 | +19.18% |
| 2024 | 2024-12-31 | €847,255 | €107,371 | +14.51% |
| 2023 | 2023-12-31 | €739,884 | €17,149 | +2.37% |
| 2022 | 2022-12-31 | €722,735 | €225,631 | +45.39% |
| 2021 | 2021-12-31 | €497,104 | €36,910 | +8.02% |
| 2020 | 2020-12-31 | €460,194 | −€289,318 | −38.60% |
| 2019 | 2019-12-31 | €749,512 | — | — |
Genenta Science S.p.A stock-based compensation trends
Over the last five fiscal years, Genenta Science S.p.A's stock-based compensation increased from €460,194 to €1.0M, a change of €549,544.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genenta Science S.p.A source filings ↗